Fig. 3: Kaplan–Meier analyses in the efficacy population.
a Progression-free survival in full analysis set (n = 23). b Duration of response among all patients who responded (n = 22). Source data are provided as a Source Data file.
Fig. 3: Kaplan–Meier analyses in the efficacy population. | Nature Communications
